Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Spriet

Showing results (101-110 of 237) with videos related to

Pageof 24
Sort By:
International Journal of Clinical Pharmacy|July 4, 2012
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challengeLiesbeth Decoutere, Sabrina De Winter, Liesbeth Vander Weyden, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of DegradationMatthias Gijsen, Benjamin Filtjens, Pieter Annaert, et al.
Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearancePeter Declercq, Matthias Gijsen, Björn Meijers, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 26, 2021
Introduction to Bayesian statistics: a practical framework for clinical pharmacistsLorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, et al.
Drugs & Aging|December 5, 2016
Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical OutcomeLorenz Van der Linden, Liesbeth Decoutere, Karolien Walgraeve, et al.
International Journal of Antimicrobial Agents|September 29, 2024
Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokineticsSalma M Bahnasawy, Neil J Parrott, Matthias Gijsen, et al.
Infection|December 6, 2024
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasisOmar Elkayal, Yannick Hoffert, Beatrijs Mertens, et al.
BMC Medical Informatics and Decision Making|July 5, 2022
End-users feedback and perceptions associated with the implementation of a clinical-rule based Check of Medication Appropriateness serviceCharlotte Quintens, Willy E Peetermans, Lorenz Van der Linden, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2022
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumoniaErwin Dreesen, Matthias Gijsen, Omar Elkayal, et al.
Pageof 24

Showing results (101-110 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Clinical Pharmacy|July 4, 2012
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challengeLiesbeth Decoutere, Sabrina De Winter, Liesbeth Vander Weyden, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of DegradationMatthias Gijsen, Benjamin Filtjens, Pieter Annaert, et al.
Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearancePeter Declercq, Matthias Gijsen, Björn Meijers, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 26, 2021
Introduction to Bayesian statistics: a practical framework for clinical pharmacistsLorenz Roger Van der Linden, Julie Hias, Karolien Walgraeve, et al.
Drugs & Aging|December 5, 2016
Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical OutcomeLorenz Van der Linden, Liesbeth Decoutere, Karolien Walgraeve, et al.
International Journal of Antimicrobial Agents|September 29, 2024
Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokineticsSalma M Bahnasawy, Neil J Parrott, Matthias Gijsen, et al.
Infection|December 6, 2024
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasisOmar Elkayal, Yannick Hoffert, Beatrijs Mertens, et al.
BMC Medical Informatics and Decision Making|July 5, 2022
End-users feedback and perceptions associated with the implementation of a clinical-rule based Check of Medication Appropriateness serviceCharlotte Quintens, Willy E Peetermans, Lorenz Van der Linden, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2022
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumoniaErwin Dreesen, Matthias Gijsen, Omar Elkayal, et al.
Pageof 24